Processa Pharmaceuticals, Inc. (PCSA)
2.05
-0.11
(-5.09%)
USD |
NASDAQ |
Sep 09, 09:58
Processa Pharmaceuticals Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 29, 2026 | 2.044 |
| June 26, 2026 | 1.960 |
| June 25, 2026 | 1.992 |
| June 24, 2026 | 2.034 |
| June 23, 2026 | 2.129 |
| June 22, 2026 | 2.192 |
| June 18, 2026 | 2.234 |
| June 17, 2026 | 2.266 |
| June 16, 2026 | 2.203 |
| June 15, 2026 | 2.329 |
| June 12, 2026 | 2.287 |
| June 11, 2026 | 2.498 |
| June 10, 2026 | 2.087 |
| June 09, 2026 | 2.145 |
| June 08, 2026 | 2.550 |
| June 05, 2026 | 2.656 |
| June 04, 2026 | 2.898 |
| June 03, 2026 | 2.951 |
| June 02, 2026 | 3.077 |
| June 01, 2026 | 2.666 |
| May 29, 2026 | 2.698 |
| May 28, 2026 | 2.782 |
| May 27, 2026 | 2.519 |
| May 26, 2026 | 2.635 |
| May 22, 2026 | 2.793 |
| Date | Value |
|---|---|
| May 21, 2026 | 2.703 |
| May 20, 2026 | 2.751 |
| May 19, 2026 | 2.751 |
| May 18, 2026 | 2.898 |
| May 15, 2026 | 3.120 |
| May 14, 2026 | 3.235 |
| May 13, 2026 | 2.687 |
| May 12, 2026 | 2.698 |
| May 11, 2026 | 2.835 |
| May 08, 2026 | 2.877 |
| May 07, 2026 | 3.025 |
| May 06, 2026 | 2.898 |
| May 05, 2026 | 2.803 |
| May 04, 2026 | 2.824 |
| May 01, 2026 | 2.687 |
| April 30, 2026 | 2.846 |
| April 29, 2026 | 2.793 |
| April 28, 2026 | 2.998 |
| April 27, 2026 | 3.146 |
| April 24, 2026 | 3.141 |
| April 23, 2026 | 3.151 |
| April 22, 2026 | 3.235 |
| April 21, 2026 | 2.914 |
| April 20, 2026 | 2.856 |
| April 17, 2026 | 3.267 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.699 |
| Corcept Therapeutics, Inc. | 17.79 |
| Veru, Inc. | 1.538 |
| Johnson & Johnson | 7.639 |
| Eli Lilly & Co. | 31.57 |
Price to Book Value Related Metrics
| Price | 2.05 |
| Earnings Yield | -272.6% |
| Market Cap | 5.726M |